德力股份: 关于全资子公司德力玻璃终止部分对外投资事项的公告

Investment Overview - Anhui Delixi Daily Glass Co., Ltd. approved the establishment of two wholly-owned subsidiaries: Delixi (Beihai) Glass Co., Ltd. and Delixi Pharmaceutical Glass Co., Ltd., with an investment of 100 million yuan each [1] - The company has decided to terminate the investment projects for both subsidiaries due to market changes and strategic considerations [2][3] Termination Reasons - Both projects have not commenced substantial construction, and the expected returns have significantly changed, leading to increased uncertainty [2] - The company has also canceled plans for a private placement to raise funds for the Delixi Pharmaceutical Glass project due to market conditions [2] Investment Status and Future Plans - As of June 30, 2025, the investment status is as follows: - Beihai Company: Registered capital of 100 million yuan, invested 102.787 million yuan, with a loss of 25.39 million yuan - Delixi Pharmaceutical Glass: Registered capital of 50 million yuan, fully invested with no profit [2] - The Beihai Company will sign agreements with the local government to repurchase land at the original auction price of 95 million yuan by October 30, 2025 [2] Impact of Termination - The termination of these projects is a strategic adjustment based on market changes and will not adversely affect the company's operations or harm minority shareholders' interests [3]